SEATTLE, Calif. -
Feb. 20, 2025 -
PRLog -- The Quaestio announces the launch of its latest "Synthetic Biology Playbook" report, offering an in-depth analysis of the fast-evolving synthetic biology landscape. Modelled after the success of The Quaestio's KnowledgeHub platform — launched in September — this comprehensive report delivers useful insights for decision-makers, innovators, and investors seeking to adopt and accelerate synthetic biology.
An All-Encompassing View of Synthetic Biology
The new report serves as a definitive guide for stakeholders across the ecosystem. It goes beyond market size and forecasts, diving into players, technologies, funding patterns, patents, papers, and regulatory frameworks shaping the field.
Key Highlights
- Market Deep-Dive
- Market Overview 2024–2029: Projections on global synthetic biology growth, segmented by geography, technology, application, and end-use.
- Growth & Opportunities: An in-depth look at high-potential sectors, including gene therapy, advanced materials, and novel chassis organisms.
- SynBio Ecosystem
- 2024 Player Map: A detailed breakdown of developers, adopters, and key ecosystem enablers.
- Emerging Startups: Profiles of new entrants spun out from top-tier universities or stealth mode.
- Application Landscape: Industry-specific segmentation highlighting medical, chemical, and materials sub-segments.
- Geographical Landscape
- Regional Insights: Comprehensive coverage of synthetic biology hotspots, including the United States, China, Denmark, India, Japan, and more.
- Regulatory & Policy Updates: Latest legal frameworks and policy implementations impacting market entry and growth.
- Technology Frontiers
- Cost & Safety: Addressing challenges such as DNA hacking, mirror bacteria, and decreasing sequencing costs.
- Innovations: Breakthroughs in AI-driven gene editing, cell-free systems, and chassis design.
- Market Dynamics
- News & Industry Activities Overview: Month-over-month analysis of major industry events, strategic collaborations, acquisitions, and product launches that are reshaping the market landscape.
- Collaborations & Consolidations: Detailed insights into recent mergers, strategic partnerships, and market exits, providing a snapshot of the competitive dynamics.
- Funding Trends
- Investment Landscape: Detailed breakdown of venture investments, seed funding, series A, and government grants, including regional and monthly funding insights.
- Top Investors & Venture Arms: Analysis of key funding sources, highlighting major investors driving innovation in synthetic biology.
- Patents & Papers
- Intellectual Property Insights: Comprehensive data on patent filings, classifications, and key research focus areas, offering a clear view of the competitive innovation landscape.
- Scientific Publications: Analysis of industry research trends, top journals, and influential papers that are shaping the field.
- Predictions
- Expert forecasts on the trajectory of synthetic biology, highlighting emerging technologies and market opportunities through 2025.
"Over the last five years, synthetic biology has witnessed unprecedented growth, with 52% of total industry funding ($47.9B) and 41% of new players (670) entering the field since 2019" — Zuzer, Lead Researcher at The Quaestio.Access the Report:
KnowledgeHub for Synthetic Biology (
https://www.thequaestio.com/kh-synthetic-biology)